Population-based case-control study of AhR (aryl hydrocarbon receptor) and CYP1A2 polymorphisms and breast cancer risk.

Ji-Rong Long; Kathleen M Egan; Lisa Dunning; Xiao-Ou Shu; Qiuyin Cai; Hui Cai; Qi Dai; Jordan Holtzman; Yu-Tang Gao; Wei Zheng

doi:10.1097/01.fpc.0000189803.34339.ed

Population-based case-control study of AhR (aryl hydrocarbon receptor) and CYP1A2 polymorphisms and breast cancer risk.

Identifier:nobleid.org/w1/20260515/13B5EB80

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/13B5EB80.svg?ark=w1%2F20260515%2F13B5EB80)](https://nobleid.org/work/w1/20260515/13B5EB80)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Population-based case-control study of AhR (aryl hydrocarbon receptor) and CYP1A2 polymorphisms and breast cancer risk.

Identifier:nobleid.org/w1/20260515/13B5EB80

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/13B5EB80.svg?ark=w1%2F20260515%2F13B5EB80)](https://nobleid.org/work/w1/20260515/13B5EB80)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work